According to GlobalData’s medical device pipeline database, 39 PTA Peripheral DCB Catheters devices are in various stages of development globally. GlobalData’s report PTA Peripheral DCB Catheters provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 28 are in active development, while the remaining 13 are in an inactive stage of development. There are eight products in the early stages of development, and the remaining 20 are in the late stages of development.
A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. PTA Peripheral DCB catheters provide fast, short-term, homogenous, local drug delivery to the vessel wall, while preserving the anatomy of the vessel, promoting enhanced vessel healing, and reducing the need for prolonged dual antiplatelet therapy. They can be used to treat native and in-stent restenosis (ISR), bifurcations, small vessels, and long lesions. One unit refers to one PTA Peripheral DCB Catheter.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed PTA Peripheral DCB Catheters pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of PTA Peripheral DCB Catheters devices. Overall, most of these PTA Peripheral DCB Catheters pipeline devices are being developed by private entities.
Key players involved in the active development of PTA Peripheral DCB Catheters include Zylox-Tonbridge Medical Technology, SurModics, Vascular Nanotransfer Technologies, Acotec Scientific, Concept Medical, Contego Medical, Cordis US, Dingke Medical Technology (Suzhou), eucatech and Lifetech Scientific (Shenzhen).
For a complete picture of the developmental pipeline for PTA Peripheral DCB Catheters devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
